The only drug-related adverse events observed are typically anticipated with gene therapy administration, the company noted. ・It added that a proactive, short-course immune modulation regimen in ...

A San Antonio family is asking the community for support as their 12-year-old son lives with a rare genetic disease that ...

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today presented at the 2026 MDA Clinical and Scientific Conference, long-term data from its MESA ...

At the 2026 MDA Conference in Orlando, Genethon unveiled new two‑year efficacy data for its gene therapy candidate GNT0004, a key milestone for Duchenne muscular dystrophy research.

A RECOMMENDATION for the HSE not to cover the cost of a drug to help children with a rare muscular disease has been blasted by families. Last year, The Irish Sun highlighted the plight of ...

Sarcopenic obesity is an emerging health concern in India where people with excess body fat also experience severe muscle ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

Taking collagen supplements regularly supports bone and muscle health in adults, improving strength and quality of life.

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or ...

The following segment was excerpted from the Harbor Health Care ETF Q4 2025 Commentary.During the fourth quarter, the Harbor Health Care ETF ...

A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal ...

March 11 (Reuters) - Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy in patients with Duchenne muscular dystrophy showed continued ...